MST1 and cardiac hypertrophy: The key finding of this study is that treatment with the Mst1/2 inhibitor XMU‐MP‐1 improved cardiac function and reduced apoptosis and fibrosis in a mouse model of cardiac hypertrophy due to pressure overload.